Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G WARNER

Showing results (381-390 of 435) with videos related to

Pageof 44
Sort By:
Plos One|September 7, 2019
Polysaccharide-based liquid storage and transport media for non-refrigerated preservation of bacterial pathogensJanine R Hutchison, Shelby M Brooks, Zachary C Kennedy, et al.
Annals of Surgical Oncology|August 14, 2025
Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable CholangiocarcinomaYawen Dong, Vanja Podrascanin, Zhihao Li, et al.
Annals of Surgical Oncology|August 28, 2025
ASO Visual Abstract: Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel in Borderline Resectable CCA: A Real-World Exploratory AnalysisYawen Dong, Jonas Santol, Vanja Podrascanin, et al.
Annals of Surgical Oncology|August 5, 2025
Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory AnalysisYawen Dong, Jonas Santol, Vanja Podrascanin, et al.
Annals of Surgical Oncology|June 26, 2026
The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic CholangiocarcinomaYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Molecular Therapy Oncolytics|March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancerSang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Annals of Surgical Oncology|July 4, 2026
ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic CholangiocarcinomaYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
Journal of the American College of Surgeons|April 7, 2023
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive PatientsHallbera Gudmundsdottir, Jennifer A Yonkus, Roberto Alva-Ruiz, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2022
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancerShyambabu Chaurasiya, Annie Yang, Zhifang Zhang, et al.
Pageof 44

Showing results (381-390 of 435) with videos related to

Sort By:
Pageof 44
Plos One|September 7, 2019
Polysaccharide-based liquid storage and transport media for non-refrigerated preservation of bacterial pathogensJanine R Hutchison, Shelby M Brooks, Zachary C Kennedy, et al.
Annals of Surgical Oncology|August 14, 2025
Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable CholangiocarcinomaYawen Dong, Vanja Podrascanin, Zhihao Li, et al.
Annals of Surgical Oncology|August 28, 2025
ASO Visual Abstract: Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel in Borderline Resectable CCA: A Real-World Exploratory AnalysisYawen Dong, Jonas Santol, Vanja Podrascanin, et al.
Annals of Surgical Oncology|August 5, 2025
Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory AnalysisYawen Dong, Jonas Santol, Vanja Podrascanin, et al.
Annals of Surgical Oncology|June 26, 2026
The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic CholangiocarcinomaYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Molecular Therapy Oncolytics|March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancerSang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Annals of Surgical Oncology|July 4, 2026
ASO Visual Abstract: The Effect of Neoadjuvant Therapy on Post-Recurrence Overall Survival After Curative Resection for Intrahepatic CholangiocarcinomaYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Annals of Surgical Oncology|April 30, 2024
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and PeritoneumHallbera Gudmundsdottir, Alessandro Fogliati, Travis E Grotz, et al.
Journal of the American College of Surgeons|April 7, 2023
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive PatientsHallbera Gudmundsdottir, Jennifer A Yonkus, Roberto Alva-Ruiz, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2022
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancerShyambabu Chaurasiya, Annie Yang, Zhifang Zhang, et al.
Pageof 44